Insider Trading History of Technology Partners Affiliates Vii Lp

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Technology Partners Affiliates Vii Lp since 2006. The trader's CIK number is 1133704. At the time of the last reporting, Technology Partners Affiliates Vii Lp was the 10% Owner of Soleno Therapeutics Inc. (stock ticker symbol SLNO). Also see all insider trading activities at Soleno Therapeutics Inc.

Note that in the past TECHNOLOGY PARTNERS AFFILIATES VII LP also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Iomai Corp (IOMI) by Technology Partners Affiliates Vii Lp

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 IOMI 5,174 $36,218 0 $0 0 $0

Yearly summary of insider trading at Soleno Therapeutics Inc (SLNO) by Technology Partners Affiliates Vii Lp

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 SLNO 0 $0 22,682 $46,080 0 $0
2017 SLNO 77,752 $0 0 $0 0 $0


Insider trading activities at 2 companies by Technology Partners Affiliates Vii Lp:

1. Iomai Corp (IOMI)

2. Soleno Therapeutics Inc (SLNO)

Table 1. Insider trading of Iomai Corp (IOMI) by Technology Partners Affiliates Vii Lp

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-02-06 IOMI Buy 5,174 7.00 36,218

Table 2. Insider trading of Soleno Therapeutics Inc (SLNO) by Technology Partners Affiliates Vii Lp

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-09-13 SLNO Sale 2,501 2.00 5,002
2018-09-12 SLNO Sale 8,301 2.02 16,784
2018-09-11 SLNO Sale 11,880 2.04 24,294
2017-03-07 CAPN Buy 77,752 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Technology Partners Affiliates Vii Lp (10% Owner of Soleno Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.